Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taipei Exchange - Delayed Quote TWD

EPS Bio Technology Corp. (4183.TWO)

Compare
20.70
-2.40
(-10.39%)
At close: 10:08:00 AM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Po-Hsiung Kuo VP & Financial Officer -- -- --
Zhitai Huang Accounting Supervisor -- -- --
Ching-Nien Lo Vice President -- -- --
Cheh-Heng Lin Vice President -- -- --

EPS Bio Technology Corp.

No. 8, R&D Road III
Hsinchu Science Park
Hsinchu City, 30076
Taiwan
886 3 668 6868 https://www.epsbio.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
109

Description

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

Corporate Governance

EPS Bio Technology Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 24, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers